510(k) device
Levo Tinnitus Masking Software Device
Otoharmonics Corp · Masker, Tinnitus (KLW, Class II) · First FDA decision Jul 18, 2014, newest Jul 18, 2014Tinnitus
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
3,862
Naming "Levo"
MAUDE reports
10
Brand "Levo", since 2015
PubMed studies
1,201
Mentioning "Levo"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Levo Tinnitus Masking Software Device
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
K140845 · Decided Jul 18, 2014 · 107 days after receipt
Device type: Masker, Tinnitus (KLW) · Otolaryngology (ENT)
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Levocarnitine for End Stage Renal DiseaseNational analysisReview closedCAG-00077NUpdated Sep 14, 2026
- Levocarnitine for use in the Treatment of Carnitine Deficiency in ESRD PatientsNational determinationOn the books230.19Updated Dec 2, 2024
Clinical trials
Device studies on ClinicalTrials.gov that name "Levo", any status and sponsor, newest update first.
- Rate of Bony Fusion Using NanoBone® Synthetic Bone Graft Versus Local Autologous Bone Graft.Completed
Artoss Inc.Not on our public-company list
NCT04615260 · 29 participants · Start Jul 19, 2021 · Primary completion Dec 31, 2024
Device: NanoBone · For: Degenerative Disc Disease; Spondylolisthesis
Sites: Worcester, Massachusetts
- Combined Pulsed-field Ablation (PFA) and Left Atrial Appendage Occlusion Using Watchman Flx or AmuletPivotal-lookingActive, not recruiting
Prince of Wales Hospital, Shatin, Hong KongAcademic, hospital or other
NCT05560204 · 200 participants (planned) · Start Jan 1, 2023 · Primary completion Dec 31, 2027
Device: Combined Pulsed-field Ablation (PFA) + Left Atrial Appendage Occlusion (LAAO) · For: Combined Pulsed-field Ablation (PFA)
Sites: Jordon, Hong Kong; Hong Kong, Hong Kong; Taipa, Macau
Medtronic - MITGPublic (MDT)
NCT07351071 · 137 participants (planned) · Start Dec 30, 2025 · Primary completion Apr 30, 2027
Device: Signia™ circular stapler with Tri-Staple™ Technology (Signia™ Circular Stapling system) · For: Colorectal Anastomosis; Left-sided Colon Resection; Anastomotic Leak and 8 more
Sites: New Haven, Connecticut; Tampa, Florida; Marietta, Georgia · 11 sites in all
3,859 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Levo", and for the whole product code for context.
This brand
10 reports: 6 malfunction, 4 injury, 0 death
Whole product code KLW
4 reports: 1 malfunction, 3 injury, 0 death
Newest reports for this brand
- Levo ArmInjury
Mizuho Orthopedic Systems, Inc.
2921578-2026-00025 · Received Sep 2, 2026 · Event dated Aug 6, 2026
Device type: Table, Surgical With Orthopedic Accessories, Ac-Powered (JEA)
Device problem as coded: Insufficient Device Problem Information
Patient problem as coded: Laceration(s)
- LEVO STANDARD PACKAGEInjury
MIZUHO ORTHOPEDIC SYSTEMS, INC.
2921578-2026-00016 · Received Jun 19, 2026 · Event dated May 22, 2026
Device type: Table, Surgical With Orthopedic Accessories, Ac-Powered (JEA)
Device problem as coded: Use of Device Problem; Unintended Movement
Patient problem as coded: Laceration(s)
3015289316-2022-00001 · Received Jul 27, 2022 · Event dated Jul 11, 2022
Device type: Suture, Surgical, Absorbable, Polydioxanone (NEW)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Unspecified Infection
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Levo"[tiab]. The summary above synthesizes these.
- Levo-Arterenol.
Tainter ML, Tullar BF, Luduena FP · Science · 1948
- Drugs for hypothyroidism.
Med Lett Drugs Ther · 2023
- Levaquin Gets a Pass.
Rashidi A, Kaiser T, Holtan SG, et al. · Biol Blood Marrow Transplant · 2020Research Support, Non-U.S. Gov't
- Levo-Tryptophan Promotes Osteogenesis Through Calcium-Sensing Receptor.
Li P, Li Y, Wang X, et al. · FASEB Bioadv · 2025
- Combined Levo-tetrahydropalmatine and diphenyleneiodonium chloride enhances antitumor activity in hepatocellular carcinoma.
Yin X, Zhang J, Zhao W, et al. · Pharmacol Res · 2022Research Support, Non-U.S. Gov't
- [Antiemetic properties of levo-sulpiride].
Guslandi M · Minerva Med · 1990English Abstract, Review
- Levo-tetrahydropalmatine: A new potential medication for methamphetamine addiction and neurotoxicity.
Liu L, Liu M, Zhao W, et al. · Exp Neurol · 2021Research Support, Non-U.S. Gov't, Review
- Take It or Levo It: An Updated Look at the Use of Levosimendan to Prevent Low Cardiac Output Syndrome in Pediatric Patients.
Staudt GE, Londergan BP, Eagle SS · J Cardiothorac Vasc Anesth · 2022Editorial, Comment
- Bibliometric analysis of levosimendan.
Zhao XS, Yu YP, Yao YT · Int J Cardiol Heart Vasc · 2025Review
- Levo-tetrahydropalmatine ameliorates neuropathic pain by inhibiting the activation of the Clec7a-MAPK/NF-κB-NLRP3 inflammasome axis.
Wu D, Wang P, Zhao C, et al. · Phytomedicine · 2023
- The absorption of liquid levo-thyroxine is not significantly impaired by food intake.
De Luca F · Acta Biomed · 2016Editorial
Other devices of this type
Also filed under product code KLW.
- Tinnitus Sound Generator ModuleGN Hearing A/S · 510(k) 2020
- Tinnitus Sound Generator ModuleGn Resound A/S · 510(k) 2015
- Multiflex Tinnitus TechnologyStarkey Laboratories, Inc. · 510(k) 2020
- SoundCure Serenade Tinnitus Treatment SystemSoundcure, Inc. · 510(k) 2015
- Levo Gen 2 Tinnitus Therapy SystemLevo Medical Corporation · 510(k) 2026
- Tinnitus TherapySivantos GmbH · 510(k) 2026
- Peace N Quiet (0.7.0)Pnq Health · 510(k) 2024
- Tinearity G1 (6103)Duearity AB · 510(k) 2023
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.